정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 940 | Recruiting | Outpatient Treatment With CoVid-19 With Prexablu | Sars Cov 2 | Drug: Sublingual Methylene blue Other: Control patients |
Phase 1 | Hospital Reg. Lic. Adolfo Lopez Mateos | OTHER_GOV | 46 | All | 18 Years | Hospital Regional Lic Adolfo Lopez Mateos, Mexico City, Ciudad De Mexico CDMX (Mexico City), Mexico |
| 939 | Withdrawn | Outpatient Use of Ivermectin in COVID-19 | Covid19 | Drug: Ivermectin Pill Drug: Placebo |
Phase 3 | Temple University | OTHER | 0 | All | 18 Years | Temple University Hospital, Philadelphia, Pennsylvania, United States |
| 938 | Active, not recruiting | Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin | Overactive Bladder Syndrome | Drug: IncobotulinumtoxinA 100 UNT Injection [Xeomin] Drug: OnabotulinumtoxinA 100 UNT [Botox] |
Phase 3 | University Of Perugia | OTHER | 140 | All | 18 Years ~ 80 Years | Antonella Giannantoni, Siena, SI, Italy |
| 937 | Not yet recruiting | Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines | Covid-19 Vaccine | Biological: CoronoVac Vaccine | Not Applicable | Izmir Bakircay University, Cigli Regional Training Hospital, Mu?la Sıtkı Kocman University | OTHER | 20 | Male | 35 Years ~ 65 Years | Kadirhan Ozdemir, ?zmir, Turkey |
| 936 | Not yet recruiting | Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 Vaccines | Covid-19 Vaccine | Biological: CoronoVac Vaccine | Not Applicable | Izmir Bakircay University, Cigli Regional Training Hospital, Mu?la Sıtkı Kocman University | OTHER | 20 | Female | 35 Years ~ 65 Years | Kadirhan Ozdemir, ?zmir, Turkey |
| 935 | Recruiting | Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora | Coronavirus Infection | Other: Oxygen-ozone therapy, probiotic supplementation and Standard of care Dietary Supplement: SivoMixx (200 billion) Drug: Azithromycin Drug: hydroxychloroquine |
Phase 2 | Roberto Poscia MD, PhD | OTHER | 152 | All | 18 Years | Francesco Pugliese, Rome, RM, Italy |
| 934 | Not yet recruiting | Ozone Auto-hemotherapy for COVID-19 Pneumonia | COVID-19 Pneumonia | Biological: Ozone auto-hemotherapy | Phase 3 | Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta, Clinica Nuestra Senora del Rosario | OTHER | 208 | All | 18 Years ~ 90 Years | Hospital Universitari Dr Josep Trueta, Girona, Spain Clinica Nuestra Senora del Rosario, Ibiza, Spain Hospital Quiron Rey Juan Carlos I, Madrid, Spain Hospital Universitario 12 de Octubre, Madrid, Spain Hospital Universitario Infanta Leonor, Madrid, Spain Hospital Universitario Principe de Asturias de Alcala de Henares, Madrid, Spain Fundacio Althaia de Manresa, Manresa, Spain Hospital Vithas Valencia Consuelo, Valencia, Spain Hospital Clinico Universitario de Valladolid, Valladolid, Spain Clinica Claro, Vigo, Spain |